Posts Tagged ‘patent expiration’

New patent expiration for Gemini Labs drug OXANDRIN

Annual Drug Patent Expirations for OXANDRIN Oxandrin is a drug marketed by Gemini Labs Llc and is included in one NDA. There are four patents protecting this drug and one…
The post New patent expiration for Gemini Labs drug OXANDRIN appeared firs…


New patent expiration for Jazz Pharms drug FAZACLO ODT

Annual Drug Patent Expirations for FAZACLO+ODT Fazaclo Odt is a drug marketed by Jazz Pharms Iii and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Jazz Pharms drug FAZACLO ODT appeared f…


New patent expiration for Shionogi Inc drug RYBIX ODT

Annual Drug Patent Expirations for RYBIX+ODT Rybix Odt is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting this drug. This drug…
The post New patent expiration for Shionogi Inc drug RYBIX ODT appeared fir…


Drug Patent Expirations for the Week of November 19, 2017

CIALIS (tadalafil) Lilly Patent: 5,859,006 Expiration: Nov 21, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post D…


New patent expiration for Mallinckrodt Hosp drug INOMAX

Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …


New patent expiration for Merck Sharp drug INVANZ

Annual Drug Patent Expirations for INVANZ Invanz is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Merck Sharp drug INVANZ appeared first on Dru…


New patent expiration for Novartis drug STARLIX

Annual Drug Patent Expirations for STARLIX Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Novartis drug STARLIX appeared …


New patent expiration for Sankyo drug PRELAY

Annual Drug Patent Expirations for PRELAY Prelay is a drug marketed by Sankyo and is included in one NDA. There are two patents protecting this drug. This drug has forty-five…
The post New patent expiration for Sankyo drug PRELAY appeared first o…


Drug Patent Expirations for the Week of November 12, 2017

INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …


New patent expiration for Janssen Pharms drug INVEGA TRINZA

Annual Drug Patent Expirations for INVEGA+TRINZA Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug INVEGA TRINZA …


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: